Concepedia

Yvonne Lassere

YL

14

Publications

902

Citations

12

H-Index

1994

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Taiho Pharmaceutical (Japan)

Yvonne Lassere is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1994–2010

14

Publications

14

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.

Richard Pazdur, Yvonne Lassere, Verna A. Rhodes et al. · Journal of Clinical Oncology · 1994 · 206 citations

Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.

D H Ho, Richard Pazdur, W Covington et al. · PubMed · 1998 · 124 citations

, , +11

Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors.

Paulo M. Hoff, Everardo D. Saad, Jaffer A. Ajani et al. · PubMed · 2003 · 97 citations

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS‐102 in patients with solid tumors

David S. Hong, James L. Abbruzzese, K. R. Bogaard et al. · Cancer · 2006 · 86 citations

Phase I Study of Preoperative Oral Uracil and Tegafur Plus Leucovorin and Radiation Therapy in Rectal Cancer

Paulo M. Hoff, Nora A. Janjan, Everardo D. Saad et al. · Journal of Clinical Oncology · 2000 · 62 citations

Rows per page

1–5 of 14